How Much Did Comet Bio Raise?
Funding & Key Investors

Comet Bio, a food technology innovator, has secured $22M in total capital, with its most recent financing round totaling $22M. This major strategic investment underscores the company's progress in developing sustainable food solutions.

The company's latest funding event, a Series C round, occurred on July 21, 2021, signaling a significant phase of growth and market expansion for Comet Bio.

What is Comet Bio?

Comet Bio
Hospitals & Physicians ClinicsMedical Practice ManagementConsumer Services

Comet Bio is an award-winning food technology company with operations in London, Ontario, and Schaumburg, Illinois. It specializes in creating healthy and sustainable products through patented upcycling technology. The company's flagship product, Arrabina Arabinoxylan Plant Fiber Extract, is a premium prebiotic dietary fiber known for its superior tolerability and functionality. Additionally, Comet Bio offers Sweeterra syrups, a sustainable, lower-sugar alternative to traditional sweeteners that does not compromise on taste or performance. This focus on upcycling and functional ingredients positions Comet Bio as a key player in the burgeoning sustainable food market.

How much funding has Comet Bio raised?

Comet Bio has raised a total of $22M across 1 funding round:

2021

Series C

$22M

Series C (2021): $22M with participation from Louis Dreyfus Company, Open Prairie Ventures, Sofinnova Partners, and BDC Capital

Key Investors in Comet Bio

Louis Dreyfus Company

Louis Dreyfus Company, based in Rotterdam, Netherlands, is a major agricultural goods merchant and processor, involved in various sectors including food, feed, and bioenergy, suggesting a strategic interest in Comet Bio's sustainable ingredient technology.

Open Prairie Ventures

Open Prairie Ventures is a private equity firm focused on agriculture and rural America, likely investing in Comet Bio due to its innovative upcycling technology and sustainable product offerings within the food sector.

Sofinnova Partners

Sofinnova Partners, a leading European venture capital firm in life sciences, specializes in healthcare and sustainability, indicating a strong alignment with Comet Bio's mission to develop functional and sustainable food ingredients.

What's next for Comet Bio?

The substantial enterprise-level funding Comet Bio has attracted, particularly its Series C financing, indicates a strategic pivot towards scaling operations and expanding market reach. This capital infusion is expected to accelerate the commercialization of its Arrabina prebiotic fiber and Sweeterra syrups, further solidifying its position in the global food ingredients sector. Future growth will likely involve strategic partnerships and broader distribution channels to meet increasing consumer demand for healthier and more sustainable food options.

See full Comet Bio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Food & BeverageManufacturingRetailGrocery Retail
Automotive PartsManufacturingAutomobile Parts StoresRetail
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding Comet Bio Financial Insights

What are the most recent funding rounds that Comet Bio has completed, and what were the funding rounds?
Comet Bio has recently completed 1 funding rounds: Series C on Jul 21, 2021.
What is the total amount of funding Comet Bio has raised to date?
Comet Bio has raised a total of $22M in funding to date.
How many funding rounds has Comet Bio completed?
Comet Bio has completed 1 funding rounds.
How much funding did Comet Bio raise in its most recent funding round?
Comet Bio raised $22M in its most recent funding round.
Who are the lead investors in Comet Bio's latest funding round?
The lead investor in Comet Bio's latest funding round was Louis Dreyfus Company. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Comet Bio's history?
The largest funding round in Comet Bio's history was $22M.
See more information about Comet Bio